Derivative Instruments (Tables)

12 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

As of March 31, 2019, the Company had no outstanding derivative contracts.

As of March 31, 2018, the Company had the following derivative contracts recorded at fair value:

	Designated Derivative Contracts			Non-Designated Derivative Contracts			Total
Notional value	$	126,332		$	4,802		$	131,134
Fair value recorded in other current assets	950			—			950
Fair value recorded in other accrued expenses	(143		)	(10		)	(153		)

Schedule of location and amount of gains and losses related to derivatives designated as hedging instruments reported in consolidated financial statements

The following table summarizes the effect of Designated Derivative Contracts:

	Years Ended March 31,
	2019		2018			2017
Amount of gain (loss) recognized in OCI (effective portion)	$	8,355	$	(9,593	)	$	8,208
Amount of gain (loss) reclassified from AOCL into net sales (effective portion)	8,675		(8,541		)	7,082
Amount of gain excluded from effectiveness testing recognized in SG&A expenses	1,918		1,376			534

The following table summarizes the income tax effect for unrealized gains or losses for Designated Derivative Contracts recorded in AOCL:

	Years Ended March 31,
	2019		2018		2017
Income tax expense (benefit)*	$	77	$	439	$	(423	)

*These amounts are inclusive of the income tax effects from the Tax Reform Act reclassified from AOCL to retained earnings in the consolidated balance sheets.

Schedule of location and amount of gains and losses related to derivatives not designated as hedging instruments reported in consolidated financial statements

The following table summarizes the effect of Non-Designated Derivative Contracts:

	Years Ended March 31,
	2019		2018			2017
Amount of gain (loss) recognized in SG&A expenses	$	1,393	$	(2,574	)	$	2,202